Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2019
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian CancerKrishnansu S Tewari, Robert A Burger, Danielle Enserro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell CarcinomaJoseph J Caumanns, Katrien Berns, G Bea A Wisman, et al.
Cancers|September 9, 2022
Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group StudyYovanni Casablanca, Guisong Wang, Heather A Lankes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2010
Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009Edward L Trimble, Michael J Birrer, William J Hoskins, et al.
Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.
Cell Reports. Medicine|January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancerDongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2008
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancerLin Zhang, Stefano Volinia, Tomas Bonome, et al.
Nature Communications|April 26, 2023
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5LChristopher J LaFargue, Paola Amero, Kyunghee Noh, et al.
The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2011
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association ConsortiumJennifer Permuth-Wey, Zhihua Chen, Ya-Yu Tsai, et al.
Pageof 23